InvestorsHub Logo

jimmy667

06/19/18 10:49 PM

#1742 RE: INTL #1741

They own or license all the IP on iRNA. This is a panacea type technology. Can addresses all diseases caused by defective genetics. Including. Drum roll please. Pre dispositions to heart disease. This company will never make it to Phase II in anything as a $1.5 Billion MC company. This is a potential sixty bagger.